… escape caused by S changes that occurred in the immunocompromised host. Notably, the
S mutations we studied foreshadowed the appearance of emerging SARS-CoV-2 variants. …

… Immunocompromised individuals and particularly those with hematologic malignancies are
at increased risk for SARS-CoV-… states of immunologic vulnerability to SARS-CoV-2 and how …

Purpose SARS-CoV-2 infection in immunocompromised hosts is challenging, and prolonged
viral shedding can be a common complication in these patients. We describe the clinical, …

… immunocompromised hosts during SARS-CoV-2 infection is not fully understood. We used a
hamster model of SARS-CoV… 19, to determine the dynamics of SARS-CoV-2 replication and …

… Of note, 23% of patients with hematologic malignancy had no detectable anti-SARS-CoV-2
T-cell responses. In another cohort of 79 COVID-19 patients, 36 immunocompromised hosts …

… nasopharyngeal and bronchoalveolar-lavage SARS-CoV-2 RT-… immunocompromised
persons effectively clear SARS-CoV-2 … evolution associated with an immunocompromised state. …

… We assume that, for each pathogen, the immunocompromised host will demonstrate reduced
resistance to infection, atypical clinical signs and symptoms, more rapid progression, and …

… Since the start of the COVID-19 pandemic in late 2019, five SARS-CoV-2 variants of concern
… SARS-CoV-2 infection in immunocompromised populations might propagate SARS-CoV-2 …

… : Intra-host SARS-CoV-2 evolution during chronic infection in immunocompromised hosts
has … Methods: Using a deep sequencing approach, we investigated the SARS-CoV-2 intra-host …

… , SARS-CoV-2 RNA was no longer detected. We observed marked within-host genomic
evolution of SARS-CoV… Our data indicate that certain immunocompromised individuals may shed …